Form 4: DENTSPLY SIRONA Exec Boosts Equity Holdings

Sentiment:

Insider Transaction Report


DENTSPLY SIRONA's EVP, Richard C. Rosenzweig, acquired additional common stock and phantom stock through dividend reinvestment.

Summary

  • Richard C. Rosenzweig, Executive Vice President, Corporate Development, General Counsel & Secretary of DENTSPLY SIRONA Inc., increased his equity holdings.
  • On October 10, 2025, Rosenzweig acquired 766.323 shares of common stock in the form of Restricted Stock Units (RSUs) at a price of $0 per share.
  • These RSUs represent dividends on previously awarded RSUs and are subject to the same vesting terms as the underlying awards, converting to common stock on a 1:1 basis.
  • He also acquired 80.9848 shares of phantom stock under the Supplemental Executive Retirement Plan (SERP) as accrued dividends, with each share being the economic equivalent of one share of common stock and valued at $11.98.
  • Following these transactions, Rosenzweig directly beneficially owns 85,183.54 shares of common stock and 6,142.9981 shares of phantom stock.

Sentiment

Score: 7

Explanation: The executive's increased equity holdings through routine dividend reinvestment align management's interests with shareholders, reflecting a positive, albeit standard, accumulation of company stock.

Positives

  • Increased beneficial ownership by a key executive, Richard C. Rosenzweig, aligns management's interests more closely with shareholders.
  • The acquisition of shares through dividend reinvestment suggests a long-term holding strategy and confidence in the company's future.

Negatives

  • The acquisitions were through dividend reinvestment and not open market purchases, meaning no direct cash investment by the executive for these specific shares.

Related Party Transactions

  • Acquisition of 766.323 shares of common stock (in the form of RSUs) by Richard C. Rosenzweig from DENTSPLY SIRONA Inc. as dividends on existing awards.
  • Acquisition of 80.9848 shares of phantom stock by Richard C. Rosenzweig from DENTSPLY SIRONA Inc. as accrued dividends under the Supplemental Executive Retirement Plan.

Stakeholder Impact

  • Shareholders: Increased alignment of executive interests with shareholder value due to higher equity ownership.
  • Employees: No direct impact on general employees.
  • Customers/Suppliers/Creditors: No direct impact.

Key Dates

DateDescription
10/10/2025Date of transaction for the acquisition of common stock (RSUs) and phantom stock (SERP).
10/15/2025Date the Form 4 was signed by the attorney-in-fact for Richard C. Rosenzweig.

Recommendation

hold

The filing details a routine acquisition of equity through dividend reinvestment by an executive, which is a standard part of compensation and does not provide new information warranting a change in investment recommendation. It reinforces executive alignment but is not a catalyst for significant price movement.

Keywords

DENTSPLY SIRONA, XRAY, Richard C. Rosenzweig, Form 4, insider transaction, executive compensation, equity acquisition, restricted stock units, phantom stock, dividend reinvestment

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.